MacLaren N - Search Results

1

Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.

Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF. Villanueva R, et al. Among authors: maclaren n. Thyroid. 2000 Sep;10(9):791-8. doi: 10.1089/thy.2000.10.791. Thyroid. 2000. PMID: 11041456

2

Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome.

Maclaren N, Chen QY, Kukreja A, Marker J, Zhang CH, Sun ZS. Maclaren N, et al. J Soc Gynecol Investig. 2001 Jan-Feb;8(1 Suppl Proceedings):S52-4. doi: 10.1016/s1071-5576(00)00109-x. J Soc Gynecol Investig. 2001. PMID: 11223374 Review.

3

Multiple immuno-regulatory defects in type-1 diabetes.

Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N. Kukreja A, et al. Among authors: maclaren n. J Clin Invest. 2002 Jan;109(1):131-40. doi: 10.1172/JCI13605. J Clin Invest. 2002. PMID: 11781358 Free PMC article.

4

NKT cell defects in NOD mice suggest therapeutic opportunities.

Kukreja A, Costi G, Marker J, Zhang CH, Sinha S, Sun Z, Maclaren N. Kukreja A, et al. Among authors: maclaren n. J Autoimmun. 2002 Nov;19(3):117-28. doi: 10.1006/jaut.2002.0609. J Autoimmun. 2002. PMID: 12419282

5

Immunopathology of immune-mediated (type 1) diabetes.

Marker J, Maclaren N. Marker J, et al. Among authors: maclaren n. Clin Lab Med. 2001 Mar;21(1):15-30. Clin Lab Med. 2001. PMID: 11321933 Review.

6

NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates.

Kukreja A, Maclaren NK. Kukreja A, et al. Diabetes Technol Ther. 2002;4(3):323-33. doi: 10.1089/152091502760098465. Diabetes Technol Ther. 2002. PMID: 12165171 Review.

7

Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes.

Ergun-Longmire B, Marker J, Zeidler A, Rapaport R, Raskin P, Bode B, Schatz D, Vargas A, Rogers D, Schwartz S, Malone J, Krischer J, Maclaren NK. Ergun-Longmire B, et al. Ann N Y Acad Sci. 2004 Dec;1029:260-77. doi: 10.1196/annals.1309.057. Ann N Y Acad Sci. 2004. PMID: 15681764 Clinical Trial.

8

Human CD1D gene expression is regulated by LEF-1 through distal promoter regulatory elements.

Chen QY, Zhang T, Pincus SH, Wu S, Ricks D, Liu D, Sun Z, Maclaren N, Lan MS. Chen QY, et al. Among authors: maclaren n. J Immunol. 2010 May 1;184(9):5047-54. doi: 10.4049/jimmunol.0901912. Epub 2010 Apr 2. J Immunol. 2010. PMID: 20363964

9

Insulin resistance syndrome in children.

Ten S, Maclaren N. Ten S, et al. Among authors: maclaren n. J Clin Endocrinol Metab. 2004 Jun;89(6):2526-39. doi: 10.1210/jc.2004-0276. J Clin Endocrinol Metab. 2004. PMID: 15181020 Review.

10

Insulin pump therapy from the time of diagnosis of type 1 diabetes.

Ramchandani N, Ten S, Anhalt H, Sinha S, Ching J, Finkelstein A, Maclaren NK. Ramchandani N, et al. Among authors: maclaren nk. Diabetes Technol Ther. 2006 Dec;8(6):663-70. doi: 10.1089/dia.2006.8.663. Diabetes Technol Ther. 2006. PMID: 17109598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters